Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 7
Treatment-assignment count: 0
Stratification count: 0
Trial Selection Rising
NTRK fusion
NSCLC · Small Molecule Inhibitor
NTRK fusion is flagged as trial selection rising because public trials show inclusion required evidence in 8 contexts. FDA CDx context should be reviewed manually. Threshold text varies across public records.
Threshold snippets
Fragmentation view
Threshold count: 16
Common snippets: BRAF V600E | MET exon 14 skipping | BRAF V600E
Threshold label: Fragmented
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Not Found
CDx maturity score: 1/5
Confidence: Medium
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT05153408 | https://clinicaltrials.gov/study/NCT04382300 | https://clinicaltrials.gov/study/NCT03175224 | https://clinicaltrials.gov/study/NCT06984588 | https://clinicaltrials.gov/study/NCT03228667 | https://clinicaltrials.gov/study/NCT05435846 | https://clinicaltrials.gov/study/NCT06031688 | https://clinicaltrials.gov/study/NCT04270591